Genetics and the metabolic syndrome

Area of Science:

• Dermatology and Endocrinology
• Genetics and Cardiovascular Risk Assessment

Background:

• Metabolic syndrome (MetS), initially termed "syndrome X," is a cluster of risk factors increasing cardiovascular and diabetic risk.
• Increasingly, dermatological conditions are identified as cutaneous markers of MetS.
• Dermatologists are encouraged to assess cardiovascular risk in patients with these skin conditions.

Purpose of the Study:

• To review the evidence linking dermatoses such as acanthosis nigricans, psoriasis, and hidradenitis suppurativa to MetS.
• To explore the potential common causalities and genetic underpinnings of these associations.
• To highlight the importance of recognizing cutaneous manifestations of MetS.

Main Methods:

• Literature review of studies investigating the association between specific dermatoses and MetS.
• Examination of evidence regarding the genetics of psoriasis, hidradenitis suppurativa, and acanthosis nigricans in relation to MetS.
• Analysis of studies showing improved dermatological outcomes with MetS treatment.

Main Results:

• Established clinical associations exist between acanthosis nigricans, psoriasis, hidradenitis suppurativa, and MetS.
• Treatment of MetS components has shown synergistic improvements in associated cutaneous pathologies.
• Despite strong clinical links, the specific genetic basis connecting these dermatoses to MetS remains largely undetermined.

Conclusions:

• Dermatologists should consider MetS in patients presenting with specific skin conditions.
• The shared pathophysiology suggests common genetic factors may link certain dermatoses with MetS.
• Further research is needed to elucidate the genetic basis for these associations and guide integrated patient management.